Due: December 04, 2023 The Joint Program Executive Office for Chemical, Biological, Radioactive, and Nuclear Defense – Enabling Biotechnologies (JPEO-CBRND-EB) program office has been established to implement comprehensive and integrated systems to rapidly discover, develop, Read More
Due: December 5, 2023 ABSTRACT Mondelez, the global snack and cookie company, seeks to optimize the design and manufacturing of their plastic trays through simulation. Through this project, the company hopes to identify modeling partners Read More
Due: December 1, 2023 The Advancing Clinical Trial Readiness (ACTR) initiative seeks to improve the nation’s ability to conduct clinical trials safely, quickly, and equitably. This is important to advance, integrate, and extend clinical trial Read More
Due: November 30, 2023 This RPI focuses on surveying the current state of engineering and medical prototypes, knowledge products, and manufacturing capacity related to military dental research. Project information papers will be reviewed by the Sponsor Read More
Due: November 15, 2023 Areas of Need: Unmanned Aerial Systems and Payloads for Infantry Support Weapons Payloads for Unmanned Naval Platforms Weapon Learning and Artificial Intelligence Compact Mobile HPM Weapon System Prototype High Accuracy Direction Read More
Due: November 20, 2023 AutoDoc Request for Project Proposals (RPP) focused on identifying a system of sensor suites that can reliably and passively collect the core data needed to identify casualty status, key tasks performed Read More
Due: November 13, 2023 The objective of this challenge is to develop initial proof of concept prototypes using Artificial Intelligence (AI) Large language models to automate the process of conducting ISD analysis, requirements development, for Read More
Due: November 14, 2023 This initiative seeks proposals from the small business community to support the development of compact tools and devices capable of manufacturing key chemical intermediates at the benchtop for research operations.
Due: November 14, 2023 The development of an accurate, inexpensive home test for Prostate Specific Antigen (PSA) is both an unmet need and an NCI priority for reducing cancer mortality by half within 25 years.
Due: November 14, 2023 The overarching goal of this initiative is to bring new alternatives for HPV testing to the market that will enable self-testing programs to be established globally at point-of-care or near point-of-care.